Tag: ResMed

SAN DIEGO – A joint venture between ResMed and Verily to study the health and financial impacts of undiagnosed and untreated sleep apnea has been renamed Primasun.  ResMed and Verily, a subsidiary of Alphabet, first joined forces in 2018.  “We need a full night’s sleep right alongside a healthy diet and regular exercise for a strong immune system, the most energy, our best mood – in essence, to be our best selves,” said Primasun CEO Jonathon...

SAN DIEGO – ResMed is positioning a new online shop as a way for the manufacturer to be a “strong partner” for its HME provider customers.  The company last week launched shop.ResMed.com to sell its AirMini travel CPAP devices to cash-paying customers.  “By setting a benchmark for the online patient experience, we’re maximizing patients’ awareness of and demand for the products and services HMEs provide,”...

SAN DIEGO – ResMed on March 16 began offering its AirMini CPAP and related masks and accessories to cash-paying customers through a new website shop.ResMed.com.  “Over 54 million Americans have sleep apnea – over 80% of whom are undiagnosed,” the company states. “Our mission is to drive awareness of the disease, plus how easy and effective today’s digitally connected home solutions are. We believe this will further normalize the condition,...

SAN DIEGO – For half of Americans, stress over the past year of the pandemic is negatively impacting the quality of their sleep, according to the results of nationwide survey of 1,000 adults conducted by ResMed.  While COVID-related stresses are often noticeable, one of the biggest stealers of sleep might be something people can’t easily detect: sleep apnea, the company says.  “While data show that stress and worry are key factors impacting many people’s...

SAN DIEGO – ResMed incurred a $13.9 million restructuring expense in the second quarter of its fiscal year 2021 as a result of closing its portable oxygen concentrator business.  The company stopped selling its Mobi POCs in November.  “Going forward, the cessation of the POC business will have an immaterial impact on both group revenue and earnings per share,” said Brett Sandercock, CFO, during a conference call on...

SAN DIEGO – ResMed reported revenues increased to $800 million for the three months ended Dec. 31, 2020, a 7% increase compared to the same period in 2019.  Net income was $179.5 million vs. $160.6 million.  “Our second quarter results reflect continued solid performance and positive trends across our business, resulting in top-line growth,” said Mick Farrell, CEO. “In our core markets of sleep apnea, COPD and asthma, we are seeing continued sequential improvement...

SAN DIEGO – ResMed has ended its three-year foray into the portable oxygen concentrator market due to “market conditions.”  The company says payers and HME providers are relying less on POCs for Stage 2 and Stage 3 COPD patients, dampening demand for the devices.  “ResMed has determined that it can successfully execute its respiratory care strategy and provide the most benefits to patients, HMEs, clinicians and all other stakeholders by reinvesting its...

SAN DIEGO – Tandem Diabetes Care has named Raj Sodhi, president of the software as a service (SaaS) business at ResMed, as an independent member of its board of directors effective Jan. 1. He brings to Tandem more than 25 years of digital strategy experience, SaaS commercialization and operations across multiple industries, including health care, financial services and telecom. “We are pleased to welcome Raj to our board of directors at this important next stage of Tandem’s...

SAN DIEGO - ResMed benefited from $40 million in sales for ventilators and accessories in the first quarter of its fiscal year 2021 - again helping to compensate for sluggish new patient volume for CPAP devices due to the COVID-19 pandemic. In the last quarter, ResMed recorded $125 million in sales for vents and, at the time, the company was “muted” on whether demand for vents would continue into the first quarter of 2021. It did, but ResMed expects sales to be “significantly...

SAN DIEGO - ResMed reported revenue of $751.9 million for the first quarter of its fiscal year 2021, a 10% increase compared to the same period in 2020. Net income was $178.4 million vs. $120.1 million, a 48% increase. Revenue in the U.S., Canada and Latin America, excluding the company's Software as a Service, grew 9%, driven by strong sales of masks and increased demand for ventilators due to the COVID-19 pandemic, partially offset by a decrease in demand for sleep devices. “Our first quarter...